Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Clinical trial NCT03373435 · COMPLETED
Trial details
- NCT number
- NCT03373435
- Sponsor
- Eiger BioPharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-19
- Primary completion
- 2019-01-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.